femhrt is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Norethindrone Acetate; Ethinyl Estradiol.
| Product ID | 0430-0145_3653e9d8-0a0c-40c9-8fa6-a4dcd6f85ddf | 
| NDC | 0430-0145 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | femhrt | 
| Generic Name | Norethindrone Acetate/ethinyl Estradiol | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2009-10-01 | 
| Marketing End Date | 2022-04-30 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021065 | 
| Labeler Name | Allergan, Inc. | 
| Substance Name | NORETHINDRONE ACETATE; ETHINYL ESTRADIOL | 
| Active Ingredient Strength | 1 mg/1; ug/1 | 
| Pharm Classes | Progesterone Congeners [CS],Progestin [EPC],Estrogen Receptor Agonists [MoA],Estrogen [EPC] | 
| NDC Exclude Flag | N | 
| Marketing Start Date | 2009-10-01 | 
| Marketing End Date | 2022-04-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021065 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2009-10-01 | 
| Marketing End Date | 2013-06-03 | 
| Marketing Category | NDA | 
| Application Number | NDA021065 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2009-10-01 | 
| Marketing Category | NDA | 
| Application Number | NDA021065 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2009-10-01 | 
| Marketing End Date | 2014-02-19 | 
| Ingredient | Strength | 
|---|---|
| NORETHINDRONE ACETATE | .5 mg/1 | 
| SPL SET ID: | 0fece0aa-2b9c-40a3-975e-1ef2c2ef72f2 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0430-0145 | femhrt | norethindrone acetate/ethinyl estradiol | 
| 16714-407 | Larin 1.5/30 | Norethindrone Acetate/Ethinyl Estradiol | 
| 16714-408 | Larin 1/20 | Norethindrone Acetate/Ethinyl Estradiol | 
| 51862-872 | Microgestin 1.5/30 | Norethindrone Acetate/Ethinyl Estradiol | 
| 51862-868 | Microgestin 1/20 | Norethindrone Acetate/Ethinyl Estradiol | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  FEMHRT  75098981  2289177 Live/Registered | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED 1996-05-06 |